The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors
Author:
Affiliation:
1. Department of Thoracic Head & Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA
2. The University of Texas MD Anderson Cancer Center, UTHealth at Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA
Abstract
Funder
CPRIT
NIH
Rexanna’s Foundation for Fighting Lung Cancer
University of Texas MD Anderson Lung Cancer Moon Shots Program
Publisher
MDPI AG
Link
https://www.mdpi.com/2072-6694/16/14/2507/pdf
Reference123 articles.
1. Update 2020: Management of Non-Small Cell Lung Cancer;Alexander;Lung,2020
2. Jain, A.S., Prasad, A., Pradeep, S., Dharmashekar, C., Achar, R.R., Ekaterina, S., Victor, S., Amachawadi, R.G., Prasad, S.K., and Pruthvish, R. (2021). Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway. Front. Oncol., 11.
3. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
4. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;Brahmer;N. Engl. J. Med.,2015
5. Acquired Resistance to Immune Checkpoint Inhibitors;Schoenfeld;Cancer Cell,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3